Alzamend Neuro Balance Sheet Health
Financial Health criteria checks 3/6
Alzamend Neuro has a total shareholder equity of $-1.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.7M and $2.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$1.19m |
Equity | -US$1.21m |
Total liabilities | US$2.88m |
Total assets | US$1.67m |
Recent financial health updates
Recent updates
Is Alzamend Neuro (NASDAQ:ALZN) In A Good Position To Deliver On Growth Plans?
Jul 26Is Alzamend Neuro (NASDAQ:ALZN) In A Good Position To Deliver On Growth Plans?
Mar 20We're Not Very Worried About Alzamend Neuro's (NASDAQ:ALZN) Cash Burn Rate
Oct 14Alzamend stock falls amid start of AL001 dosing in healthy people in Alzheimer's trial
Oct 05Alzamend seeks FDA nod for early-stage trial of its therapy for Alzheimer’s type dementia
Sep 29Alzamend Neuro receives positive pre-IND response from FDA for AL001
Jul 18Alzamend: Biotech To Watch With 2 Drugs Targeting Multi-Billion Dollar Alzheimer's Market
Dec 18Alzamend Neuro closes $14.4M IPO
Jun 17Financial Position Analysis
Short Term Liabilities: ALZN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: ALZN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: ALZN is debt free.
Reducing Debt: ALZN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ALZN has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ALZN is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.